The differential predictive power of TyG in obese versus non-obese sarcopenic individuals likely reflects distinct pathophysiological pathways: In non-obese sarcopenia: Muscle atrophy directly impairs insulin-mediated glucose uptake, increasing the reliance on lipid metabolism. This evidence concerns the gene INS and sarcopenia.